These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 35700857)

  • 1. COVID-19-related thrombotic complications experience before and during delta wave.
    Manzur-Pineda K; O'Neil CF; Bornak A; Lalama MJ; Shao T; Kang N; Kennel-Pierre S; Tabbara M; Velazquez OC; Rey J
    J Vasc Surg; 2022 Nov; 76(5):1374-1382.e1. PubMed ID: 35700857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early experience with arterial thromboembolic complications in patients with COVID-19.
    Indes JE; Koleilat I; Hatch AN; Choinski K; Jones DB; Aldailami H; Billett H; Denesopolis JM; Lipsitz E
    J Vasc Surg; 2021 Feb; 73(2):381-389.e1. PubMed ID: 32861865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19.
    Rossio R; Tettamanti M; Galbussera AA; Gualtierotti R; Giachi A; Torri A; Montano N; Fracanzani AL; Bandera A; Nobili A; Peyvandi F;
    Intern Emerg Med; 2024 Sep; 19(6):1577-1583. PubMed ID: 38761332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
    Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
    Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection.
    Lachant DJ; Lachant NA; Kouides P; Rappaport S; Prasad P; White RJ
    J Thromb Haemost; 2020 Oct; 18(10):2640-2645. PubMed ID: 33448631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales.
    Knight R; Walker V; Ip S; Cooper JA; Bolton T; Keene S; Denholm R; Akbari A; Abbasizanjani H; Torabi F; Omigie E; Hollings S; North TL; Toms R; Jiang X; Angelantonio ED; Denaxas S; Thygesen JH; Tomlinson C; Bray B; Smith CJ; Barber M; Khunti K; Davey Smith G; Chaturvedi N; Sudlow C; Whiteley WN; Wood AM; Sterne JAC;
    Circulation; 2022 Sep; 146(12):892-906. PubMed ID: 36121907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019.
    Wada H; Shiraki K; Shimpo H; Shimaoka M; Iba T; Suzuki-Inoue K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID-19 Arterial Thrombotic Events among Three Major Permutations of COVID-19.
    Bhandari S; Joshi S; Rankawat G; Tiwaskar M; Lohmror A; Singh A
    J Assoc Physicians India; 2023 Jul; 71(7):11-12. PubMed ID: 37449687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute thrombotic manifestations of coronavirus disease 2019 infection: Experience at a large New York City health care system.
    Ilonzo N; Rao A; Safir S; Vouyouka A; Phair J; Baldwin M; Ting W; Soundararajan K; Han D; Tadros R; Marin M; Faries P
    J Vasc Surg; 2021 Mar; 73(3):789-796. PubMed ID: 32882350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and Management of COVID-19-Associated Hypercoagulability.
    Massaro G; Lecis D; Martuscelli E; Chiricolo G; Sangiorgi GM
    Card Electrophysiol Clin; 2022 Mar; 14(1):41-52. PubMed ID: 35221084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late thrombotic complications after SARS-CoV-2 infection in hemodialysis patients.
    Shabaka A; Gruss E; Landaluce-Triska E; Gallego-Valcarce E; Cases-Corona C; Ocaña J; Tato-Ribera A; Lopez-Revuelta K; Furaz-Czerpak KR; Fernández-Juárez G
    Hemodial Int; 2021 Oct; 25(4):507-514. PubMed ID: 34060217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities.
    Tan CW; Tan JY; Wong WH; Cheong MA; Ng IM; Conceicao EP; Low JGH; Ng HJ; Lee LH
    Sci Rep; 2021 Jan; 11(1):1793. PubMed ID: 33469056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous Thrombosis and SARS-CoV-2.
    Zdanyte M; Rath D; Gawaz M; Geisler T
    Hamostaseologie; 2022 Aug; 42(4):240-247. PubMed ID: 34879422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual arterial thrombotic events in Covid-19 patients.
    de Roquetaillade C; Chousterman BG; Tomasoni D; Zeitouni M; Houdart E; Guedon A; Reiner P; Bordier R; Gayat E; Montalescot G; Metra M; Mebazaa A
    Int J Cardiol; 2021 Jan; 323():281-284. PubMed ID: 32918938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
    Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
    Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in COVID-19 Survivors: A Retrospective Cohort Study.
    Lim JT; Liang En W; Tay AT; Pang D; Chiew CJ; Ong B; Lye DCB; Tan KB
    Clin Infect Dis; 2024 Jan; 78(1):70-79. PubMed ID: 37746872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review.
    Jenner WJ; Kanji R; Mirsadraee S; Gue YX; Price S; Prasad S; Gorog DA
    J Thromb Thrombolysis; 2021 Apr; 51(3):595-607. PubMed ID: 33586113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis risk assessment in patients with congenital thrombophilia during COVID - 19 infection.
    Kovac M; Mitic G; Milenkovic M; Basaric D; Tomic B; Markovic O; Zdravkovic M; Ignjatovic V
    Thromb Res; 2022 Oct; 218():151-156. PubMed ID: 36054979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.